Patient Guide: KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 39 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04165096
Status: COMPLETED
Condition: Carcinoma, Non-Small-Cell Lung
Phase: PHASE2

Find a Study Location Near You

This study is available at 39 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Gilbert, Arizona
  • Duarte, California
  • San Francisco, California
  • • And 36 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily